Private equity investor ChrysCapital was forced to remove its director from the board of Mankind Pharma and will not be able to exercise its veto rights in the company as a condition of securing merger clearance from the Indian competition authority to increase its minority stake in Intas Pharmaceuticals.The Competition Commission of